Showing results (181-190 of 530) with videos related to
Sort By:
Pageof 53
ACR Open Rheumatology|April 11, 2022
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular RiskKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.Pharmacoepidemiology and Drug Safety|May 14, 2011
Accuracy of identifying neutropenia diagnoses in outpatient claims dataSeo Young Kim, Daniel H Solomon, Jun Liu, et al.Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Brief Report: Development and Validation of a Semiautomated Method to Measure Erosion Volume in Inflammatory Arthritis by Computed Tomography ScanningJeffrey Duryea, Ruby Russell, Ellen M Gravallese, et al.Epidemiology (Cambridge, Mass.)|March 21, 2023
Comparative Safety of Gout Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Clone-censor-weight Target Trial Emulation ApproachKazuki Yoshida, Jun Liu, Rishi J Desai, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 9, 2023
Patterns of Involvement of the Hand Joints in Classical Rheumatoid ArthritisRonald J Anderson, Jing Cui, Michael E Weinblatt, et al.Arthritis Care & Research|September 24, 2010
Development and preliminary validation of a meniscal symptom indexNina N Niu, Elena Losina, Scott D Martin, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Kidney function and use of recommended medications after myocardial infarction in elderly patientsWolfgang C Winkelmayer, David M Charytan, M Alan Brookhart, et al.Medical Care|August 23, 2007
The medical license number accurately identifies the prescribing physician in a large pharmacy claims databaseM Alan Brookhart, Jerry Avorn, Jennifer M Polinksi, et al.Arthritis Care & Research|October 21, 2011
Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care SurveyDaniel H Solomon, John Z Ayanian, Ed Yelin, et al.Plos One|February 25, 2012
The prevalence and cost of unapproved uses of top-selling orphan drugsAaron S Kesselheim, Jessica A Myers, Daniel H Solomon, et al.Pageof 53